| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 17 |
| 1 | DURVALUMAB | 11 |
| 2 | PACLITAXEL | 9 |
| 3 | PEMETREXED DISODIUM | 9 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 7 |
| 5 | PEMBROLIZUMAB | 6 |
| 6 | PEMETREXED | 6 |
| 7 | CISPLATIN | 5 |
| 8 | ESOMEPRAZOLE MAGNESIUM | 5 |
| 9 | ACETAMINOPHEN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 1 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 2 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 3 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 4 | DURVALUMAB | 11 | 0.0005 |
| 5 | CEFADROXIL | 1 | 0.0005 |
| 6 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 7 | GLYCERIN SUPPOSITORY | 1 | 0.0004 |
| 8 | GLYCERIN SUPPOSITORIES | 1 | 0.0004 |
| 9 | TAFLUPROST | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 11 | 0.0005 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 3 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 4 | Cannabinoid [EPC] | 1 | 0.0001 |
| 5 | Glinide [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Platinum-based Drug [EPC] | 20 | 0.0001 |